Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Folic Acid

Unchecked
From Pharmacopedia
Folic acid (folate, pteroylglutamic acid)
Folvite; mostly generic

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Common uses
Folate-deficiency megaloblastic anemia0, Neural tube defect prevention in pregnancy0, Methotrexate-associated stomatitis/GI toxicity reduction0, Homocystinuria adjunct0
Pharmacy
Starting dose
0.4 mg PO daily (general prevention); 0.8-1 mg/d in pregnancy; 4 mg/d for women with prior NTD-affected pregnancy; 1 mg/d during methotrexate therapy
Preparations
0.4, 0.8, 1 mg OTC; 1 mg Rx; 5 mg/mL injection
US FDA Max
1 mg/d typical Rx; higher in specific indications
Pharmacology
Routes
Oral, IM, IV, SC
Onset
Hematologic response within days
Duration
N/A (replacement)
Half-life
~0.5 hours plasma; tissue retention longer
Bioavailability
High (oral)
Pregnancy
Routinely supplemented in pregnancy and preconception to prevent neural tube defects.[citation needed]
Legal status
OTC (low-dose) and Rx-only (1 mg, injectable) in US
Purported mechanism
Folic acid is the synthetic form of folate; following absorption it is reduced by dihydrofolate reductase to tetrahydrofolate (THF), the carrier of one-carbon units required for thymidylate, purine, and amino acid synthesis.0 The dramatic effect on neural tube defects (Medical Research Council Vitamin Study, 1991) led to US mandatory cereal-grain fortification (1998) and population-level NTD reduction. In folate-deficient megaloblastic anemia presenting with neurologic symptoms, B12 deficiency must be excluded first because folate alone will correct anemia while masking and potentially accelerating B12-deficient subacute combined degeneration[1].

References

edit
  1. FDA Prescribing Information, folic acid tablets, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/06006slr027_folvite_lbl.pdf